<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A woman aged 59 years with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> progressive <z:hpo ids='HP_0003198'>myopathy</z:hpo> had anti-Golgi (giantin) autoantibody in the serum </plain></SENT>
<SENT sid="1" pm="."><plain>Limb-muscle biopsy revealed <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003198'>myopathy</z:hpo> with paucity of cellular reactions and reduced immunostaining for alpha-dystroglycan </plain></SENT>
<SENT sid="2" pm="."><plain>The similarity of the current patient with cases of hereditary alpha-dystroglycanopathies (Fukuyama-type <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo>, Walker-Warburg syndrome, muscle-eye-<z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e>, <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> type 1C, and <z:hpo ids='HP_0006785'>limb-girdle muscular dystrophy</z:hpo> type 2I) suggests that the Golgi apparatus is the target organelle in a subset of <z:hpo ids='HP_0003198'>myopathies</z:hpo> </plain></SENT>
</text></document>